Androgen Receptor Attenuation of Ad5 Replication: Implications for the Development of Conditionally Replication Competent Adenoviruses-Reference-Cited by-同舟云学术

Androgen Receptor Attenuation of Ad5 Replication: Implications for the Development of Conditionally Replication Competent Adenoviruses

Published:2007-08 Issue:8 Volume:15 Page:1495-1503
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Höti Naseruddin,Li Ying,Chen Chien-Lun,Chowdhury Wasim H,Johns David C,Xia Qinghua,Kabul Arup,Hsieh Jer-Tsong,Berg Michael,Ketner Gary,Lupold Shawn E,Rodriguez Ronald

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference34 articles.

1. A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy;DeWeese;Cancer Res,2001

2. Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells;Rodriguez;Cancer Res,1997

3. Molecular determinants of resistance to antiandrogen therapy;Chen;Nat Med,2004

4. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells;Zegarra-Moro;Cancer Res,2002

5. Viral oncoprotein binding to pRB, p107, p130, and p300;Ludlow;Virus Res,1995

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses;Molecular Therapy - Oncolytics;2023-03

2. Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection;Cancers;2023-02-02

3. Proteomics characterization of the adenovirus VA1 non-coding RNA on the landscape of cellular proteome;Turkish Journal of Biochemistry;2022-09-09

4. Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids;Journal for ImmunoTherapy of Cancer;2021-08

5. Teratogenic Toxicity Evaluation of Bladder Cancer-Specific Oncolytic Adenovirus on Mice;Current Gene Therapy;2021-04-19